等待開盤 09-24 09:30:00 美东时间
-0.740
-2.98%
Magnite ( ($MGNI) ) has provided an update. On September 18, 2026, Magnite prom...
09-22 05:26
Magnite (MGNI) has promoted Brian Gephart to chief financial officer, effective October 1, 2026. Gephart will succeed David Day, who is retiring after a decade overseeing Magnite’s financial operation...
09-21 20:57
今日重点评级关注:康托·菲茨杰拉德:维持Abeona Therapeutics"超配"评级,目标价从28美元升至30美元;HC Wainwright & Co.:维持Oculis Holding"买入"评级,目标价从26美元升至39美元
09-21 16:25
Magnite promotes Brian Gephart as CFO, effective October 1, 2026, succeeding David Day, who is retiring after a decade of service. Gephart, who has served as Chief Accounting Officer since June 2021, brings over 20 years of experience in finance, accounting, and capital markets. He will oversee global financial strategy and operations, including corporate finance, accounting, reporting, investor relations, treasury, and tax. CEO Michael Barrett p...
09-21 12:30
Insiders have been trading these 5 stocks: (($CROX)), (($INOD)), (($MGNI)), (($...
09-19 21:01
Magnite Orchestration expands its omnichannel capabilities, supporting streaming, linear TV, audio, and display. It connects agents in a shared environment, enabling AI-driven buying systems to discover, evaluate, and optimize inventory. The platform integrates with partners like ITN, DIRECTV, and iHeartMedia, standardizing supply-side intelligence across media types. Magnite aims to transform media buying with agentic AI, reducing operational fr...
09-16 12:00
今日重点评级关注:富国银行:维持Pyxis Oncology"超配"评级,目标价从12美元升至19美元;Oppenheimer:维持Opus Genetics"跑赢大市"评级,目标价从10美元升至20美元
09-10 15:00
Magnite and Amnet France launched the first agentic campaign in EMEA, leveraging AI to streamline premium CTV ad execution. The collaboration reduced campaign setup time by 70% and achieved a 95% video view-through rate. Magnite's buyer agent automated tasks, enabling Amnet to focus on strategy. Barbara Thuillier-Romeri of Amnet highlighted AI's potential to enhance campaign outcomes, while Edouard Schmidt of Magnite emphasized the value of integ...
09-08 07:00
今日重点评级关注:BTIG:维持Climb Bio"买入"评级,目标价从20美元升至32美元;巴克莱:维持Alpha Tau Medical"超配"评级,目标价从17美元升至30美元
09-04 12:30
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co. cut the price target for Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) from $50 to $25. HC W...
09-03 20:35